FDA Investigator Stephen C Eason

Stephen C Eason has conducted inspections on 313 sites in 3 countries as of 28 Sep 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
313
Last Inspection Date:
28 Sep 2021
Investigator Role:
FDA Investigator
Redica ID:
100003647
Countries of Inspections:
United States of America, Iceland, South Africa
FDA Investigators that have inspected at least one site in common with Stephen C Eason:
Abdellah El Hajjam, Amanda B Athey, Amanda M Osteen, Amber G Chung, Amos C Epps, Amy C Amaro, Austin B Appler, Barbara J Holladay, Billingsley, Brandi L Garbutt, Brian P Hendrickson, Brian R Yaun, Brooke K Higgins, Brooke K Seeman, Bruce C Kovak, Bruce E Kummer, Bryan J Love, Candice C Mandera, Candice J Cortes, Carrie L Doupnik, Cecil D Mitchell, Charlean R Butler, Charles D Boison, Charles M Kerns, BLT DO, Charlotte E Wilkins, Christine M O'leary, Clara E Santiago, Clarice J Ahn, Conrad M Guardia, Cynthia A Harris, MD, RN, Cynthia White, David A Carlson, David A Trent Carlson, David J Leray, David L Chon, David P Rice, Jr, Debra D Devlieger, Decima L Washington, Dennis L Doupnik, Dianne H Milazzo, Dirk L Lincoln, Douglas A Campbell, Earl Echon, Edward P Potter, Edwin L Hobbs, Elvis D Morton, Emmanuel A Dimaano, Jr, Erik T Nagaoka, Esaw, Gale L Glinecki, Gerald D Bromley, Jr, Gerald Mierle, Gifford Whitehurst, Jr, Heath A Gerber, Hector Jcolon Torres, Jacqueline Johnson, James T Mccoy, Jason M Sluzynski, Jessica D Weber, Joell A Eifert, Joey C West, John Dan, Johnson, Jon C Polzine, Jose R Hernandez, Joseph S Fanelli, Julie A Silberberg, Justin A Hefferman, Kailee R Mason, Karen A Spencer, Karen S Anthony, Katherine M Taylor, Kenneth L Smalls, Kenneth Nieves, Kyle S Hobson, La Tasham Gunter, Latoya S Oliver Powell, Laurianne M Montonye, Lawrence Harmon, Jr, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lillian C Hsu, Linda J Eason, LT Melanie M Mayor, USPHS, Luis A Dasta, Marc A Jackson, Jr, Marcus A Ray, Margaret H Waters, Marla A Cassidy, Mary F Bodick, Mary K Leslie, Mary P Ross, Marya F Ricks, Melissa J Garcia, Michael D Ellison, Michael S Call, Mohamad A Chahine, Myra L Gemmill, Nathaniel R Esaw, Pamela M Tremarki, Pelekakis, Philip W Beck, Pratik S Upadhyay, DDC, Renisha M Shaw, Richard G Fochesato, Richard J Bashay, Rina Bhikha, Robert W Turner, Samuel M Aboagye, Sean R Moynihan, MPH, Sherry L Secrist, BLT DO, Sierra M Shockley, Slatten, Stacey A Priest, Stephanie A Madison, Stephen Eason, Susan J Essenmacher, Sylvia R Dooling, Tamara N Champion, Tania E Vizcaino, Thomas J Hudson, Thomas R Withers, Tiki J Dixon, Valeria A Moore, Vesna V Stanoyevitch, Wayne L Jefferson, Whitney S Reynolds, William A Warnick, William H Linkroum

Stephen C Eason's Documents

Publish Date Document Type Title
September, 2001 EIR Airgas, LLC - EIR, 2001-09-10
February, 2016 EIR Sabra Dipping Company, LLC - EIR, 2016-02-24
February, 2009 EIR Saadeh, Ghandi, M.D. - EIR, 2009-02-04
July, 2000 FDA 483 Lewis, Donald W., M.D. - Form 483, 2000-07-14
February, 2001 FDA 483 Frank M Ludwig MD - Form 483, 2001-02-13
September, 2000 FDA 483 Response Boehringer Ingelheim Chemicals, Inc. - Form 483R, 2000-09-12
September, 2002 EIR Bruce E. Bodner, MD - EIR, 2002-09-13
September, 2001 FDA 483 Airgas, LLC - Form 483, 2001-09-10
September, 2000 EIR Boehringer Ingelheim Chemicals, Inc. - EIR, 2000-09-08
June, 2003 EIR Richard A. Craven, MD - EIR, 2003-06-12
September, 2000 FDA 483 Boehringer Ingelheim Chemicals, Inc. - Form 483, 2000-09-08
September, 2002 FDA 483 Bruce E. Bodner, MD - Form 483, 2002-09-13
February, 2001 EIR Frank M Ludwig MD - EIR, 2001-02-13
July, 2000 EIR Lewis, Donald W., M.D. - EIR, 2000-07-14
February, 2009 FDA 483 Saadeh, Ghandi, M.D. - Form 483, 2009-02-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more